The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant FOLFIRINOX in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis.
 
Quisette Janssen
No Relationships to Disclose
 
Stefan Buettner
No Relationships to Disclose
 
Mustafa Suker
No Relationships to Disclose
 
Georgios A Margonis
No Relationships to Disclose
 
Alessandro Paniccia
No Relationships to Disclose
 
Bassel F. El-Rayes
Honoraria - Bayer; Lexicon; RTI Health Solutions
Consulting or Advisory Role - Bayer; BTG; Loxo; Merrimack; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Lexicon
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)
 
Nathan Bahary
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene
Research Funding - Newlink Genetics
 
Ian Chau
Honoraria - Amgen; Gilead Sciences; Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Five Prime Therapeutics; Lilly; MSD Oncology; Roche/Genentech; Sanofi
Research Funding - Janssen-Cilag (Inst); Lilly (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck Serono; MSD; Sanofi
 
Peter Joel Hosein
Consulting or Advisory Role - Angiodynamics; Angiodynamics; Celgene; Medtronic
 
Andrew H. Ko
Honoraria - Advance Medical; Biomedical Learning Institute; Med IQ; Medscape; Peerview; Pharmatecture; WebMD
Consulting or Advisory Role - ARMO Biosciences; AstraZeneca; Celgene; New B Innovation; Pharmacyclics; Rafael Pharmaceuticals; Seagen; Vicus Therapeutics
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Halozyme (Inst); Merck (Inst); Merrimack (Inst)
 
Jill Lacy
Consulting or Advisory Role - Celgene; KeyQuest Health; Navigant Consulting; Sirtex Medical
Travel, Accommodations, Expenses - Lilly
 
Nigel Jamieson
No Relationships to Disclose
 
Christoph Tinchon
No Relationships to Disclose
 
Kyu-Pyo Kim
No Relationships to Disclose
 
Marc G. Besselink
No Relationships to Disclose
 
Johanna Wilmink
Consulting or Advisory Role - Celgene; Novartis; Shire
Research Funding - Celgene; Novartis; Shire
 
Marjolein Y.V. Homs
No Relationships to Disclose
 
Casper H.J. van Eijck
No Relationships to Disclose
 
Matthew H. G. Katz
Consulting or Advisory Role - Abbvie; Alcresta Therapeutics; McKesson
 
Bas Groot Koerkamp
No Relationships to Disclose